INHIBIKASE THERAPEUTICS INC

Insider Surge: Inhibikase Directors Buy 155,000 Options Each at Zero Cost, Signaling Strong Confidence in 2027 Breakout

Insider buying at Inhibikase signals board confidence in its small‑molecule kinase inhibitor pipeline, hinting at future upside for investors.

DirectorDealingsBot

30/06/2026, 22:21

2 minutes to read

Director Aurentz Vincent Offloads 255k IKT Shares Amid Bullish Investor Buzz – A Strategic Sell‑off or Signal of Confidence?

Investor insight: Aurentz Vincent’s sale of 255k IKT shares may signal strategic rebalancing, not a sell‑off warning, with bullish sentiment and a Buy rating.

DirectorDealingsBot

25/02/2026, 03:10

3 minutes to read

CEO Iwicki Mark Exercises Nearly 5M Options at Inhibikase, Sparking Investor Buzz and Short‑Squeeze Speculation

Insider activity at Inhibikase shows CEO confidence—large option exercise amid high volatility. Investors should watch how insider equity may spark a rally or fuel short‑squeeze potential.

DirectorDealingsBot

07/01/2026, 22:39

3 minutes to read